Cargando…

Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease

BACKGROUND: Huntington’s disease (HD), an inherited, often late-onset, neurodegenerative disorder, is considered to be a rare, orphan disease. Research into its genetic correlates and services for those affected are inadequate in most low-middle income countries, including India. The apparent ‘incur...

Descripción completa

Detalles Bibliográficos
Autores principales: Ratna, Nikhil, Kamble, Nitish L., Venkatesh, Sowmya D., Purushottam, Meera, Pal, Pramod K., Jain, Sanjeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068943/
https://www.ncbi.nlm.nih.gov/pubmed/32164608
http://dx.doi.org/10.1186/s12883-020-01671-x
_version_ 1783505677148225536
author Ratna, Nikhil
Kamble, Nitish L.
Venkatesh, Sowmya D.
Purushottam, Meera
Pal, Pramod K.
Jain, Sanjeev
author_facet Ratna, Nikhil
Kamble, Nitish L.
Venkatesh, Sowmya D.
Purushottam, Meera
Pal, Pramod K.
Jain, Sanjeev
author_sort Ratna, Nikhil
collection PubMed
description BACKGROUND: Huntington’s disease (HD), an inherited, often late-onset, neurodegenerative disorder, is considered to be a rare, orphan disease. Research into its genetic correlates and services for those affected are inadequate in most low-middle income countries, including India. The apparent ‘incurability’ often deters symptomatic and rehabilitative care, resulting in poor quality of life and sub-optimal outcomes. There are no studies assessing disease burden and outcomes from India. METHODS: We attempted to evaluate individuals diagnosed to have HD at our tertiary-care center between 2013 and 2016 for clinical symptoms, functionality, mortality, follow up status through a structured interview, clinical data from medical records and UHDRS-TFC scoring. RESULTS: Of the 144 patients, 25% were untraceable, and another 17 (11.8%) had already died. Mean age at death and duration of illness at the time of death, were 53 years and 7 years respectively, perhaps due to suicides and other comorbidities at an early age. The patients who could be contacted (n = 81) were assessed for morbidity and total functional capacity (TFC). Mean CAG repeat length and TFC score were 44.2 and 7.5 respectively. Most individuals (66%) were in TFC stage I and II and could perhaps benefit from several interventions. The TFC score correlated inversely with duration of illness (p < 0.0001). The majority were being taken care of at home, irrespective of the physical and mental disability. There was a high prevalence of psychiatric morbidity (91%) including suicidal tendency (22%). Three of the 17 who died had committed suicide, and several other families reported suicidal history in other family members. Only about half the patients (57%) maintained a regular clinical follow-up. CONCLUSIONS: This study demonstrates the poor follow-up rates, significant suicidality and other psychiatric symptoms, sub-optimal survival durations and functional outcomes highlighting the need for holistic care for the majority who appear to be amenable to interventions.
format Online
Article
Text
id pubmed-7068943
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-70689432020-03-18 Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease Ratna, Nikhil Kamble, Nitish L. Venkatesh, Sowmya D. Purushottam, Meera Pal, Pramod K. Jain, Sanjeev BMC Neurol Research Article BACKGROUND: Huntington’s disease (HD), an inherited, often late-onset, neurodegenerative disorder, is considered to be a rare, orphan disease. Research into its genetic correlates and services for those affected are inadequate in most low-middle income countries, including India. The apparent ‘incurability’ often deters symptomatic and rehabilitative care, resulting in poor quality of life and sub-optimal outcomes. There are no studies assessing disease burden and outcomes from India. METHODS: We attempted to evaluate individuals diagnosed to have HD at our tertiary-care center between 2013 and 2016 for clinical symptoms, functionality, mortality, follow up status through a structured interview, clinical data from medical records and UHDRS-TFC scoring. RESULTS: Of the 144 patients, 25% were untraceable, and another 17 (11.8%) had already died. Mean age at death and duration of illness at the time of death, were 53 years and 7 years respectively, perhaps due to suicides and other comorbidities at an early age. The patients who could be contacted (n = 81) were assessed for morbidity and total functional capacity (TFC). Mean CAG repeat length and TFC score were 44.2 and 7.5 respectively. Most individuals (66%) were in TFC stage I and II and could perhaps benefit from several interventions. The TFC score correlated inversely with duration of illness (p < 0.0001). The majority were being taken care of at home, irrespective of the physical and mental disability. There was a high prevalence of psychiatric morbidity (91%) including suicidal tendency (22%). Three of the 17 who died had committed suicide, and several other families reported suicidal history in other family members. Only about half the patients (57%) maintained a regular clinical follow-up. CONCLUSIONS: This study demonstrates the poor follow-up rates, significant suicidality and other psychiatric symptoms, sub-optimal survival durations and functional outcomes highlighting the need for holistic care for the majority who appear to be amenable to interventions. BioMed Central 2020-03-12 /pmc/articles/PMC7068943/ /pubmed/32164608 http://dx.doi.org/10.1186/s12883-020-01671-x Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Ratna, Nikhil
Kamble, Nitish L.
Venkatesh, Sowmya D.
Purushottam, Meera
Pal, Pramod K.
Jain, Sanjeev
Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
title Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
title_full Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
title_fullStr Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
title_full_unstemmed Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
title_short Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
title_sort psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in huntington’s disease
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7068943/
https://www.ncbi.nlm.nih.gov/pubmed/32164608
http://dx.doi.org/10.1186/s12883-020-01671-x
work_keys_str_mv AT ratnanikhil psychiatricmorbidityandpoorfollowupunderliesuboptimalfunctionalandsurvivaloutcomesinhuntingtonsdisease
AT kamblenitishl psychiatricmorbidityandpoorfollowupunderliesuboptimalfunctionalandsurvivaloutcomesinhuntingtonsdisease
AT venkateshsowmyad psychiatricmorbidityandpoorfollowupunderliesuboptimalfunctionalandsurvivaloutcomesinhuntingtonsdisease
AT purushottammeera psychiatricmorbidityandpoorfollowupunderliesuboptimalfunctionalandsurvivaloutcomesinhuntingtonsdisease
AT palpramodk psychiatricmorbidityandpoorfollowupunderliesuboptimalfunctionalandsurvivaloutcomesinhuntingtonsdisease
AT jainsanjeev psychiatricmorbidityandpoorfollowupunderliesuboptimalfunctionalandsurvivaloutcomesinhuntingtonsdisease